Comparison of Different Therapeutic Effects of T-MIST for Chronic Idiopathic Tinnitus

Table 3

Potential factors associated with T-MIST.

	Univariate analysis		Multivariate analysis
	Vanishing/unchanged	Remission/unchanged	Vanishing/unchanged	Remission/unchanged
	OR (95% CI)	OR (95% CI)	OR (95% CI)	OR (95% CI)
Predictor
Age (years)	0.995 (0.971-1.019)	0.975 (0.958-0.991)	0.996 (0.967-1.026)	0.975 (0.958-0.993)
Initial onset time (years)	0.996 (0.972-1.020)	0.977 (0.961-0.994)
Course of disease (years)	0.991 (0.917-1.071)	0.976 (0.925-1.031)
Gender (male)	1.191 (0.590-2.407)	1.223 (0.756-1.978)
Left ear (both)	0.518 (0.208-1.290)	1.359 (0.780-2.368)
Right ear (both)	0.937 (0.416-2.113)	0.919 (0.503-1.681)
Hearing loss (no)	0.989 (0.457-2.142)	0.860 (0.511-1.447)
THIB	1.000 (0.985-1.016)	0.997 (0.987-1.008)
THIA	0.995 (0.979-1.011)	0.997 (0.986-1.008)
VASB	0.988 (0.835-1.170)	0.949 (0.845-1.066)
VASA	0.881 (0.749-1.036)	0.992 (0.829-1.026)
THID	1.018 (0.993-1.045)	1.001 (0.981-1.021)
VASD	1.212 (1.000-1.470)	1.074 (0.927-1.244)
Tinnitus loudness (dB)	0.991 (0.976-1.007)	0.990 (0.980-1.001)
Tinnitus frequency (<4623.5 Hz)	3.435 (1.631-7.235)	1.169 (0.721-1.896)	2.853 (1.185-6.874)	1.027 (0.613-1.721)
Average hearing (dB)	0.727 (0.499-1.059)	0.809 (0.646-1.013)
RI	0.063 (0.031-0.127)	0.394 (0.257-0.604)	0.071 (0.035-0.143)	0.399 (0.259-0.614)

Vanishing, remission, unchanged: the treatment results of T-MIST; THIB, THIA, VASB, VASA, THID, VASD: THI before treatment, THI after treatment, VAS before treatment, VAS after treatment, THIB-THID, VASB-VASD; average hearing: average hearing thresholds of 500 kHz, 1000 kHz, and 2000 kHz; RI: residual inhibition test.